◆英語タイトル：Relmada Therapeutics Inc (RLMDD) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treatment of neuropathic pain; REL-1028 BuTab, an oral tablet form of buprenorphine; REL-1015 LevoCap ER, an abuse resistant form of broad spectrum opioid levorphanol; and REL-1021 MepiGel, a topical gel dosage form of local anesthetic mepivacaine. It also develops analgesics medicines. The company offers products in the areas of chronic pain due to cancer, depression, ophthalmology, mitochondrial diseases, Rett syndrome and peripheral neuropathy. Relmada Therapeutics is headquartered in New York, the US.
Relmada Therapeutics Inc Key Recent Developments
Mar 23,2021: Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
Mar 18,2021: Relmada Therapeutics to Report Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on March 23, 2021
Mar 11,2021: Relmada Therapeutics Announces Participation in the Oppenheimer 31st Annual Healthcare Conference
Jul 13,2020: Relmada Therapeutics announces uplisting to the Nasdaq Global Select Market
May 26,2020: Relmada Therapeutics appoints Molly Harper as Executive Vice President of operations
This comprehensive SWOT profile of Relmada Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Relmada Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Relmada Therapeutics Inc – Key Information
Relmada Therapeutics Inc – Overview
Relmada Therapeutics Inc – Key Employees
Relmada Therapeutics Inc – Key Employee Biographies
Relmada Therapeutics Inc – Key Operational Heads
Relmada Therapeutics Inc – Major Products and Services
Relmada Therapeutics Inc – History
Relmada Therapeutics Inc – Company Statement
Relmada Therapeutics Inc – Locations And Subsidiaries
Relmada Therapeutics Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Relmada Therapeutics Inc – Business Description
Relmada Therapeutics Inc – Corporate Strategy
Relmada Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Relmada Therapeutics Inc – Strengths
Relmada Therapeutics Inc – Weaknesses
Relmada Therapeutics Inc – Opportunities
Relmada Therapeutics Inc – Threats
Relmada Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Relmada Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Relmada Therapeutics Inc, Key Information
Relmada Therapeutics Inc, Key Ratios
Relmada Therapeutics Inc, Share Data
Relmada Therapeutics Inc, Major Products and Services
Relmada Therapeutics Inc, History
Relmada Therapeutics Inc, Key Employees
Relmada Therapeutics Inc, Key Employee Biographies
Relmada Therapeutics Inc, Key Operational Heads
Relmada Therapeutics Inc, Other Locations
Relmada Therapeutics Inc, Subsidiaries
Relmada Therapeutics Inc, Key Competitors
Relmada Therapeutics Inc, SWOT Analysis
Relmada Therapeutics Inc, Ratios based on current share price
Relmada Therapeutics Inc, Annual Ratios
Relmada Therapeutics Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Relmada Therapeutics Inc (RLMDD)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら